Objectives and methods A postmarketing survey was carried out to determine the efficacy
and tolerability of Valette®(dienogest 2.0 mg and ethinylestradiol 0.03 mg) in routine …

BACKGROUND: Estradiol valerate/dienogest (E2V/DNG) is a combined oral contraceptive
(COC) with 2 new hormonal entities and a unique 4-phasic dosing regimen indicated for …

Background Women would prefer more natural hormonal contraception, with high reliability,
good tolerability, a simple dosing schedule and possibly some health advantages. Aim To …

Abstract▴ Estradiol valerate/dienogest is an oral contraceptive for women that combines the
natural estrogen estradiol with the 19-nortestosterone derivative dienogest in a four-phasic …

Background To investigate the efficacy and safety of a combined oral contraceptive
containing estradiol valerate and dienogest (EV/DNG) in healthy Asian women. Methods In …

Purpose: The aim of the study was to examine the discontinuation rate of hormonal
contraception with estradiol valerate (E2V) and dienogest (DNG). Patients and methods: We …

Objective: To review the pharmacology, pharmacokinetics, efficacy, and safety of the new
oral contraceptive estradiol valerate/dienogest. Data Sources: Searches of PubMed (1966 …

Purpose: Evaluate bleeding patterns for the Liletta® levonorgestrel 52 mg intrauterine
system (IUS) using the World Health Organization Belsey definitions. Material and methods …

Oral contraceptives (OCs) have been used worldwide by women for more than 50 years for
the purpose of preventing pregnancy. According to the Centers for Disease Control and …

Importance of the field: Since ethinyl estradiol is a potent activator of hepatic enzymes, the
use of natural estradiol (E2) has been studied; but, until recently, bleeding control has …